Ultrasound Training Among Endocrine Oncology Surgeons: What is Best Practice?

Abstract

Background: We aimed to determine training levels and utilization of surgeon-performed ultrasound (SPUS) among endocrine surgeons. Methods: Survey of American Association of Endocrine Surgeons members and recent endocrine surgery fellowship graduates. Results: Thirty-four percent (165/481) recipients completed the survey. Of 60% endocrine surgery fellowship-trained surgeons, 58% performed ultrasound during fellowship and 18% during residency. Currently, 65% employ SPUS, with significant variability: 31% without biopsy; 60% not in the operating room; 39% for lymph node mapping; 22% for long-term thyroid cancer surveillance. SPUS altered surgical decision making ‘sometimes’ (>50%) or ‘most of the time’ (31%). Support for ‘rich ultrasound exposure’ was nearly universal. Although 76% felt comfortable with SPUS interpretation, 43% nevertheless obtained additional radiology-performed ultrasound. The majority (53%) rated SPUS as ‘indispensable’. Conclusion: Ultrasound is employed by a growing number of endocrine surgeons, who view it as necessary for clinical practice though usage patterns differ. Formal SPUS education during fellowship training appears advantageous.